Gene · 5710
Papers1,432
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,432
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PHF5A as a new OncoTarget and therapeutic prospects. | Heliyon | 2023 | 37483794 | PubTator, text mining | PubMed |
| Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1. | Nat Commun | 2023 | 37474525 | PubTator, text mining | PubMed |
| UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells. | FEBS Open Bio | 2023 | 37454373 | PubTator, text mining | PubMed |
| Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice. | Cell Rep | 2023 | 37389991 | PubTator, text mining | PubMed |
| CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 37379438 | PubTator, text mining | PubMed |
| The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis. | Front Immunol | 2023 | 37359553 | PubTator, text mining | PubMed |
| PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. | Cell Death Dis | 2023 | 37355626 | PubTator, text mining | PubMed |
| An engineered cell line with a hRpn1-attached handle to isolate proteasomes. | J Biol Chem | 2023 | 37354974 | PubTator, text mining | PubMed |
| PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation. | BMC Cancer | 2023 | 37349676 | PubTator, text mining | PubMed |
| PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition. | Hum Cell | 2023 | 37336868 | PubTator, text mining | PubMed |
| Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers. | EBioMedicine | 2023 | 37257316 | PubTator, text mining | PubMed |
| PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. | Sci Transl Med | 2023 | 37256937 | PubTator, text mining | PubMed |
| Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review. | Molecules | 2023 | 37241729 | PubTator, text mining | PubMed |
| Cellular Protein Aggregates: Formation, Biological Effects, and Ways of Elimination. | Int J Mol Sci | 2023 | 37239937 | PubTator, text mining | PubMed |
| TMT-Based Comparative Proteomic Analysis of the Spermatozoa of Buck (Capra hircus) and Ram (Ovis aries). | Genes (Basel) | 2023 | 37239333 | PubTator, text mining | PubMed |
| Pbp1 associates with Puf3 and promotes translation of its target mRNAs involved in mitochondrial biogenesis. | PLoS Genet | 2023 | 37216416 | PubTator, text mining | PubMed |
| Ubiquitin-independent proteasomal degradation driven by C-degron pathways. | Mol Cell | 2023 | 37201526 | PubTator, text mining | PubMed |
| FAT10 and NUB1L cooperate to activate the 26S proteasome. | Life Sci Alliance | 2023 | 37188463 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Proteome changes in a human retinal pigment epithelial cell line during oxidative stress and following antioxidant treatment. | Front Immunol | 2023 | 37153596 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5710/papers?page=5